Bilal Yousufzai, MD
Ophthalmology · Washington, DCNPI 1023458916
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,290 of the $2,690 with a category attached, or 85.1%. 22 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 25.1% of the total.
Across 91 payments — averaging $29.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$675
- Regeneron$400
- Genentech USA, Inc.$284
- Astellas Pharma US Inc$220
- Bausch & Lomb Americas Inc.$202
- AbbVie$168
- plus $739 from 16 others
What the payments were for
- Travel & lodging$40015%
- Food & beverage$2,29085%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 21 | $675 |
| Regeneron | 1 | $400 |
| Genentech USA, Inc. | 11 | $284 |
| Astellas Pharma US Inc | 9 | $220 |
| Bausch & Lomb Americas Inc. | 9 | $202 |
| AbbVie(2 entities) | 10 | $168 |
| Harrow Eye, LLC | 1 | $133 |
| Novartis | 7 | $130 |
| Coherus Oncology, Inc. | 4 | $81 |
| Alimera Sciences, Inc. | 4 | $75 |
| Apellis Pharmaceuticals, Inc. | 3 | $67 |
| Tarsus Pharmaceuticals, Inc. | 1 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Johnson & Johnson Vision Care, Inc. | 1 | $20 |
| Oyster Point Pharma, Inc. | 1 | $19 |
| Ivantis, Inc | 1 | $19 |
| Amgen | 1 | $17 |
| Maculogix, Inc. | 1 | $16 |
| Carl Zeiss Meditec USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,690 in reported general payments places this provider in the 65th percentile of 74 ophthalmology providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 111 | $5,299 |
| Brimonidine Tartrate | 20 | $1,542 |
| Ketorolac Tromethamine | 60 | $1,211 |
| Difluprednate | 16 | $930 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 45 | $787 |
| Atropine Sulfate | 15 | $595 |
| Latanoprost | 50 | $465 |
| Ofloxacin | 33 | $464 |
| ErythromycinErythromycin Base | 19 | $264 |
| Dorzolamide Hcl | 19 | $218 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Washington
- Wiley ChambersWashington$618K
- Keesha Williams ElliottWashington$167K
- Samuel StopakWashington$33K
- Jonca BullWashington$30K
- Leslie JonesWashington$22K
- Alexander HacopianWashington$13K
- Mehdi Tavakoli DastjerdiWashington$12K
- Andrew HammerWashington$11K
- Thandeka MyeniWashington$10K
- Dipak PanigrahiWashington$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.